CN106619592A - Medicine for treating acute pharyngitis - Google Patents
Medicine for treating acute pharyngitis Download PDFInfo
- Publication number
- CN106619592A CN106619592A CN201611023827.XA CN201611023827A CN106619592A CN 106619592 A CN106619592 A CN 106619592A CN 201611023827 A CN201611023827 A CN 201611023827A CN 106619592 A CN106619592 A CN 106619592A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- pharyngitises
- cefalexin
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Abstract
The invention discloses a medicine for treating acute pharyngitis. The medicine for treating the acute pharyngitis is prepared from the following main raw materials in parts by weight: 5 to 12 parts of cefalexin, 8 to 15 parts of methimazole, 13 to 18 parts of vitamin E, 5 to 9 parts of phenprobamate, 11 to 16 parts of analginum, 2 to 6 parts of calcium gluconate, 4 to 10 parts of acyclovir and 5 to 8 parts of bromhexine hydrochloride. The medicine disclosed by the invention is used for treating the acute pharyngitis; the medicine is convenient to take, small in side effect, has the effects of clearing heat and relieving sore throat, and has the major function of treating the acute pharyngitis; practical inspection shows that the medicine has an obvious relieving effect on the acute pharyngitis.
Description
Technical field
The present invention relates to a kind of field of medicine preparation, specifically a kind of medicine for treating acute pharyngitises.
Background technology
Pharyngolaryngitis, are a kind of diseases caused by antibacterial and virus, can be divided into two kinds of acute pharyngolaryngitises and chronic pharyngolaryngitiss.
Acute pharyngolaryngitises winter-spring season is the most common, is secondary to acute rhinitises, acute sinusitis, acute tonsillitiss more, and is often measles,
The complication of the infectious disease such as influenza, scarlet fever, adult based on pharyngeal symptom, disease is just pharyngeal have it is dry itch, it is scorching hot, gradually have pain
Bitterly, increase when swallowing, excessive saliva, lateral pharyngeal band involvement then has obvious otalgia, General Symptomies significantly, have fever cold, headache,
The symptoms such as inappetence, extremities aching pain；Chronic pharyngitiss be due to acute pharyngitises treatment not thorough recurrent exerbation, switch to it is chronic,
Or because suffering from various cacorhinias, nose key obstruction, caused by long-term mouth breathing, the various chronic diseases of whole body, such as anemia, constipation, under
Respiratory tract chronic inflammation, cardiovascular disease etc. also can secondary primary disease, patient feels pharyngeal discomfort, does, itches, swollen, secretions it is many and
Causalgia, there is a foreign body sensation, and above symptom is being spoken slightly many, after edible irritable food, fatigue or is increased during Changes in weather.Treatment pharynx
Laryngitis has various methods, such as tea therapy, dietetic therapy, western medicine, treatment by Chinese herbs.And traditional remedies are not suitable for the treatment of acute pharyngitises,
Need the western medicine medicine that a kind of Small side effects, curative effect are fast.
The content of the invention
It is an object of the invention to provide a kind of medicine for treating acute pharyngitises, to solve above-mentioned background technology in propose
Problem.
For achieving the above object, the present invention provides following technical scheme：
A kind of medicine for treating acute pharyngitises, be according to the primary raw material of weight portion：Cefalexin 5-12 part, thiamazole
8-15 parts, Vitamin E 13-18 part, phenprobamate 5-9 parts, dipyrone 11-16 parts, calcium gluconate 2-6 parts, acyclovir 4-
10 parts, Bisolvon 5-8 parts.
As further scheme of the invention：The medicine of the treatment acute pharyngitises, be according to the primary raw material of weight portion：
Cefalexin 6-10 part, thiamazole 10-14 parts, Vitamin E 14-16 part, phenprobamate 5-9 parts, dipyrone 13-15 parts, Portugal
Grape Calciofon 2-6 parts, acyclovir 5-9 parts, Bisolvon 5-8 parts.
As further scheme of the invention：The medicine of the treatment acute pharyngitises, be according to the primary raw material of weight portion：
8 parts of Cefalexin, 12 parts of thiamazole, 15 parts of Vitamin E, 8 parts of phenprobamate, 14 parts of dipyrone, 4 parts of calcium gluconate, Ah
8 parts of VCV, 7 parts of Bisolvon.
A kind of preparation method of the medicine for treating acute pharyngitises, concretely comprises the following steps：
First, in pharmaceutical grade clean area, Cefalexin, thiamazole, Vitamin E, phenylpropyl alcohol are weighed by above-mentioned metering ratio
Urethane, dipyrone, calcium gluconate, acyclovir, Bisolvon, sieve, and machinery adds ultra-pure water after mixing, and place pharmacy
In mixer, mix 4-8min, control RSD≤5%, tabletting and cold drying after mixing, at 4-8 DEG C, packaging is temperature control
The medicine of acute pharyngitises must be treated.
As further scheme of the invention：Mix 6min in concrete steps.
As further scheme of the invention：Temperature control is at 6 DEG C in concrete steps.
Compared with prior art, the invention has the beneficial effects as follows：
Product of the present invention is used for the treatment of acute pharyngolaryngitises, and the drug administration is convenient, Small side effects, with relieving sore-throat by clearing away heat
Effect, cures mainly acute pharyngitises, and Jing practice tests have obvious mitigation to acute pharyngitises.
Specific embodiment
Below in conjunction with the embodiment of the present invention, the technical scheme in the embodiment of the present invention is clearly and completely described,
Obviously, described embodiment is only a part of embodiment of the invention, rather than the embodiment of whole.Based in the present invention
Embodiment, the every other embodiment that those of ordinary skill in the art are obtained under the premise of creative work is not made, all
Belong to the scope of protection of the invention.
Embodiment 1
A kind of medicine for treating acute pharyngitises, be according to the primary raw material of weight portion：5 parts of Cefalexin, thiamazole 8
Part, 13 parts of Vitamin E, 5 parts of phenprobamate, 11 parts of dipyrone, 2 parts of calcium gluconate, 4 parts of acyclovir, Bisolvon 5
Part.
A kind of preparation method of the medicine for treating acute pharyngitises, concretely comprises the following steps：
First, in pharmaceutical grade clean area, Cefalexin, thiamazole, Vitamin E, phenylpropyl alcohol are weighed by above-mentioned metering ratio
Urethane, dipyrone, calcium gluconate, acyclovir, Bisolvon, sieve, and machinery adds ultra-pure water after mixing, and place pharmacy
In mixer, mix 4min, control RSD≤5%, tabletting and cold drying after mixing, at 4 DEG C, packaging is obtained final product to be controlled temperature control
Treat the medicine of acute pharyngitises.
Embodiment 2
A kind of medicine for treating acute pharyngitises, be according to the primary raw material of weight portion：6 parts of Cefalexin, thiamazole 10
Part, 14 parts of Vitamin E, 5 parts of phenprobamate, 13 parts of dipyrone, 2 parts of calcium gluconate, 5 parts of acyclovir, Bisolvon 5
Part.
A kind of preparation method of the medicine for treating acute pharyngitises, concretely comprises the following steps：
First, in pharmaceutical grade clean area, Cefalexin, thiamazole, Vitamin E, phenylpropyl alcohol are weighed by above-mentioned metering ratio
Urethane, dipyrone, calcium gluconate, acyclovir, Bisolvon, sieve, and machinery adds ultra-pure water after mixing, and place pharmacy
In mixer, mix 4min, control RSD≤5%, tabletting and cold drying after mixing, at 4 DEG C, packaging is obtained final product to be controlled temperature control
Treat the medicine of acute pharyngitises.
Embodiment 3
A kind of medicine for treating acute pharyngitises, be according to the primary raw material of weight portion：8 parts of Cefalexin, thiamazole 12
Part, 15 parts of Vitamin E, 8 parts of phenprobamate, 14 parts of dipyrone, 4 parts of calcium gluconate, 8 parts of acyclovir, Bisolvon 7
Part.
A kind of preparation method of the medicine for treating acute pharyngitises, concretely comprises the following steps：
First, in pharmaceutical grade clean area, Cefalexin, thiamazole, Vitamin E, phenylpropyl alcohol are weighed by above-mentioned metering ratio
Urethane, dipyrone, calcium gluconate, acyclovir, Bisolvon, sieve, and machinery adds ultra-pure water after mixing, and place pharmacy
In mixer, mix 6min, control RSD≤5%, tabletting and cold drying after mixing, at 6 DEG C, packaging is obtained final product to be controlled temperature control
Treat the medicine of acute pharyngitises.
Embodiment 4
A kind of medicine for treating acute pharyngitises, be according to the primary raw material of weight portion：10 parts of Cefalexin, thiamazole 14
Part, 16 parts of Vitamin E, 9 parts of phenprobamate, 15 parts of dipyrone, 6 parts of calcium gluconate, 9 parts of acyclovir, Bisolvon 8
Part.
A kind of preparation method of the medicine for treating acute pharyngitises, concretely comprises the following steps：
First, in pharmaceutical grade clean area, Cefalexin, thiamazole, Vitamin E, phenylpropyl alcohol are weighed by above-mentioned metering ratio
Urethane, dipyrone, calcium gluconate, acyclovir, Bisolvon, sieve, and machinery adds ultra-pure water after mixing, and place pharmacy
In mixer, mix 8min, control RSD≤5%, tabletting and cold drying after mixing, at 8 DEG C, packaging is obtained final product to be controlled temperature control
Treat the medicine of acute pharyngitises.
Embodiment 5
A kind of medicine for treating acute pharyngitises, be according to the primary raw material of weight portion：12 parts of Cefalexin, thiamazole 15
Part, 18 parts of Vitamin E, 9 parts of phenprobamate, 16 parts of dipyrone, 6 parts of calcium gluconate, 10 parts of acyclovir, Bisolvon 8
Part.
A kind of preparation method of the medicine for treating acute pharyngitises, concretely comprises the following steps：
First, in pharmaceutical grade clean area, Cefalexin, thiamazole, Vitamin E, phenylpropyl alcohol are weighed by above-mentioned metering ratio
Urethane, dipyrone, calcium gluconate, acyclovir, Bisolvon, sieve, and machinery adds ultra-pure water after mixing, and place pharmacy
In mixer, mix 8min, control RSD≤5%, tabletting and cold drying after mixing, at 8 DEG C, packaging is obtained final product to be controlled temperature control
Treat the medicine of acute pharyngitises.
Medicine Jing acute and chronic toxicology tests prepared by embodiment of the present invention 1-5, without discovery toxic reaction.
Using method：
Take once every 4 hours warm water, each 2g, until recovery from illness.
Model case：
Wang, female, 21 years old, pharyngeal causalgia 8 hours, and there is low grade fever, and dry pharynx cough, diagnosis：Acute pharyngitises.Using this
Medicine prepared by bright embodiment 3, after taking once, starts effective, symptom all disappearances after 8 hours after 4 hours.
Wu, man, 35 years old, pharyngeal causalgia 10 hours, and there is sputum band blood, and pronounce hoarse, diagnosis：Acute pharyngitises.Make
With the embodiment of the present invention 3 prepare medicine, after taking once, symptom slows down, and takes again, start after 4 hours it is effective, 8 hours
Afterwards symptom all disappears.
Liu, female, 47 years old, throat causalgia 6 hours, and occur swallowing pain, cough but no phlegm, diagnosis：Acute pharyngitises.Use
The embodiment of the present invention 3 prepare medicine, after taking once, symptom slows down, and takes again, start after 6 hours it is effective, after 10 hours
Symptom all disappears.
It is obvious to a person skilled in the art that the invention is not restricted to the details of above-mentioned one exemplary embodiment, Er Qie
In the case of spirit or essential attributes without departing substantially from the present invention, the present invention can be in other specific forms realized.Therefore, no matter
From the point of view of which point, embodiment all should be regarded as exemplary, and be nonrestrictive, the scope of the present invention is by appended power
Profit is required rather than described above is limited, it is intended that all in the implication and scope of the equivalency of claim by falling
Change is included in the present invention.
Moreover, it will be appreciated that although this specification is been described by according to embodiment, not each embodiment is only wrapped
Containing an independent technical scheme, this narrating mode of description is only that for clarity those skilled in the art should
Using description as an entirety, the technical scheme in each embodiment can also Jing it is appropriately combined, form those skilled in the art
Understandable other embodiment.
Claims (6)
1. a kind of medicine for treating acute pharyngitises, it is characterised in that the primary raw material according to weight portion is：Cefalexin 5-12
Part, thiamazole 8-15 parts, Vitamin E 13-18 part, phenprobamate 5-9 parts, dipyrone 11-16 parts, calcium gluconate 2-6
Part, acyclovir 4-10 parts, Bisolvon 5-8 parts.
2. it is according to claim 1 treatment acute pharyngitises medicine, it is characterised in that the medicine of the treatment acute pharyngitises
Thing, be according to the primary raw material of weight portion：Cefalexin 6-10 part, thiamazole 10-14 parts, Vitamin E 14-16 part, phenylpropyl alcohol
Urethane 5-9 part, dipyrone 13-15 parts, calcium gluconate 2-6 parts, acyclovir 5-9 parts, Bisolvon 5-8 parts.
3. it is according to claim 1 and 2 treatment acute pharyngitises medicine, it is characterised in that the treatment acute pharyngitises
Medicine, be according to the primary raw material of weight portion：8 parts of Cefalexin, 12 parts of thiamazole, 15 parts of Vitamin E, phenprobamate 8
Part, 14 parts of dipyrone, 4 parts of calcium gluconate, 8 parts of acyclovir, 7 parts of Bisolvon.
4. a kind of preparation method of the medicine of the treatment acute pharyngitises as described in claim 1-3 is arbitrary, it is characterised in that concrete
Step is：
First, in pharmaceutical grade clean area, by above-mentioned metering ratio weigh Cefalexin, thiamazole, Vitamin E, phenprobamate,
Dipyrone, calcium gluconate, acyclovir, Bisolvon, sieve, and machinery adds ultra-pure water after mixing, and place pharmacy mixing
In machine, mix 4-8min, control RSD≤5%, tabletting and cold drying after mixing, at 4-8 DEG C, packaging is obtained final product to be controlled temperature control
Treat the medicine of acute pharyngitises.
5. it is according to claim 4 treatment acute pharyngitises medicine preparation method, it is characterised in that in concrete steps mix
Close 6min.
6. it is according to claim 4 treatment acute pharyngitises medicine preparation method, it is characterised in that the middle temperature of concrete steps
Degree control is at 6 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611023827.XA CN106619592A (en) | 2016-11-17 | 2016-11-17 | Medicine for treating acute pharyngitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611023827.XA CN106619592A (en) | 2016-11-17 | 2016-11-17 | Medicine for treating acute pharyngitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106619592A true CN106619592A (en) | 2017-05-10 |
Family
ID=58808222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611023827.XA Pending CN106619592A (en) | 2016-11-17 | 2016-11-17 | Medicine for treating acute pharyngitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106619592A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020160491A1 (en) * | 2000-01-28 | 2002-10-31 | Jian Ni | Human Serpin polynucleotides, polypeptides, and antibodies |
| CN1424084A (en) * | 2002-12-19 | 2003-06-18 | 中国人民解放军第二军医大学 | Honeysuckle flower and coptis root powder injection and its preparing method |
| CN101340902A (en) * | 2005-11-28 | 2009-01-07 | 奥加生物药业（香港）有限公司 | Materials and methods for treating viral infections with a cysteamine compound |
| CN101466716A (en) * | 2006-04-07 | 2009-06-24 | 德维洛根股份公司 | Thienopyrimidines having MNKL/MNK2 inhibiting activity for pharmaceutical compositions |
| CN101912368A (en) * | 2010-09-26 | 2010-12-15 | 上海理工大学 | Compound cefaclor suspension and preparation method thereof |
| CN104107171A (en) * | 2014-01-22 | 2014-10-22 | 邓学峰 | Cefradine composition |
| CN105851758A (en) * | 2016-05-18 | 2016-08-17 | 何凤祥 | Amino acid drink |
-
2016
- 2016-11-17 CN CN201611023827.XA patent/CN106619592A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020160491A1 (en) * | 2000-01-28 | 2002-10-31 | Jian Ni | Human Serpin polynucleotides, polypeptides, and antibodies |
| CN1424084A (en) * | 2002-12-19 | 2003-06-18 | 中国人民解放军第二军医大学 | Honeysuckle flower and coptis root powder injection and its preparing method |
| CN101340902A (en) * | 2005-11-28 | 2009-01-07 | 奥加生物药业（香港）有限公司 | Materials and methods for treating viral infections with a cysteamine compound |
| CN101466716A (en) * | 2006-04-07 | 2009-06-24 | 德维洛根股份公司 | Thienopyrimidines having MNKL/MNK2 inhibiting activity for pharmaceutical compositions |
| CN101912368A (en) * | 2010-09-26 | 2010-12-15 | 上海理工大学 | Compound cefaclor suspension and preparation method thereof |
| CN104107171A (en) * | 2014-01-22 | 2014-10-22 | 邓学峰 | Cefradine composition |
| CN105851758A (en) * | 2016-05-18 | 2016-08-17 | 何凤祥 | Amino acid drink |
Non-Patent Citations (1)
| Title |
|---|
| 王兰等: "咽立爽治疗急性咽炎的疗效观察", 《山东医大基础医学院学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102283932A (en) | Chinese patent drug for treating canker sore by external application | |
| CN106619592A (en) | Medicine for treating acute pharyngitis | |
| CN106619645A (en) | Medicine for treating acute pharyngitis | |
| CN103690583A (en) | Medicinal liquor, and preparation method and application thereof | |
| CN104758562A (en) | Medicinal liquor for treating rheumatism and preparation method thereof | |
| CN104173965B (en) | Medicated wine for curing traumatic injury and preparation method thereof | |
| CN104474100A (en) | Traditional Chinese medicine for setting of fracture | |
| CN107468870A (en) | It is a kind of to be used to treat ointment medicine of dermatitis and preparation method thereof | |
| CN104510993A (en) | Chinese medicinal composition for effective treatment of asthma and preparation method thereof | |
| CN105687806A (en) | Rhizoma Coptidis oral liquid for heat clearing and dampness eliminating, and production method thereof | |
| CN106551979A (en) | A kind of film for treating oral ulcer and preparation method thereof | |
| CN105250534A (en) | Traditional Chinese medicine composition for treating acute and chronic faucitis | |
| CN105878629A (en) | Rubbing powder for treating plantar wart | |
| CN105288528A (en) | Medicinal liquor for treating spleen-stomach disharmony | |
| CN104971112A (en) | Olive granules with functions of dispelling wind and eliminating dampness and production method | |
| CN104147528B (en) | A kind of preparation method for the medicine for treating gastric ulcer | |
| CN104083541A (en) | Traditional Chinese medicament for treating furunculosis | |
| CN102614406B (en) | Traditional Chinese medicine for prevention and treatment of intractable oral mucosal ulcer and preparation method thereof | |
| CN106389732A (en) | Traditional Chinese medicine plaster for curing common cold due to wind-cold | |
| CN107661459A (en) | One kind treats phthisical Chinese medicine composition | |
| CN105708974A (en) | Traditional Chinese medicine electuary for treating chronic pharyngolaryngitis | |
| CN108392536A (en) | A kind of Yao nationality's externally applied drug for treating fungal skin disease | |
| CN108310337A (en) | Treat composition, the treatment cough tea and preparation method thereof of cough | |
| CN104288627A (en) | Traditional Chinese medicine for treating swollen sore throat | |
| CN106038727A (en) | Traditional Chinese medicinal composition for treating temporomandibular joint disorder syndrome and method for preparing preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170510 |